BIOA
BioAge Labs Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +23.2% ·
net new positions +20.0%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 256 | $1,742 | n/a | n/a |
| Q2 2026 | 66 | +4 | 13.22M | $323.71M | +6 | −2 |
| Q1 2026 | 65 | +14 | 13.97M | $243.82M | +19 | −5 |
| Q4 2025 | 51 | +2 | 8.60M | $113.77M | +2 | n/a |
| Q3 2025 | 16 | +1 | 5.16M | $30.36M | +1 | n/a |
| Q2 2025 | 12 | +5 | 4.16M | $17.19M | +5 | n/a |
| Q1 2025 | 4 | 0 | 455.40K | $1.71M | +2 | −2 |
| Q4 2024 | 4 | -5 | 347.20K | $2.01M | +1 | −6 |
| Q3 2024 | 8 | +8 | 1.18M | $24.62M | +8 | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 1.56M | n/a | $6.43M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 2 | BlackRock ✦ (passive) | 1.29M | n/a | $5.32M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Geode Capital Management ✦ (passive) | 453.45K | +60.8% | $1.87M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Marshall Wace ✦ | 226.79K | +324.7% | $936,639 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passive) | 160.85K | +53.4% | $664,306 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 109.61K | New | $452,668 | 0.0% | New | 1 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 89.30K | New | $368,792 | 0.0% | New | 1 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 77.56K | n/a | $320,302 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 67.40K | New | $278,354 | 0.0% | New | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 64.60K | +326.6% | $266,802 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 36.07K | New | $148,981 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 31.55K | New | $130,310 | 0.0% | New | 1 | SEC ↗ ×5 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $452,668 | 0.0% |
| Renaissance Technologies | $368,792 | 0.0% |
| D. E. Shaw & Co. | $278,354 | 0.0% |
| Millennium Management | $148,981 | 0.0% |
| AQR Capital Management | $130,310 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 143 holders, 34.12M shares, $588.17M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.